<DOC>
	<DOCNO>NCT00852436</DOCNO>
	<brief_summary>The purpose study determine whether pregabalin decrease pain improve quality life patient nerve pain mouth face</brief_summary>
	<brief_title>Pregabalin Orofacial Neuropathic Pain</brief_title>
	<detailed_description>Neuropathic pain ( NP ) define pain initiate cause primary lesion dysfunction nervous system . At trigeminal area somatosensory nerve often damage dental /maxillofacial intervention , post-operative orofacial neuropathic pain ( OFNP ) estimate treated prevalence/incidence rate ~3-12 % , 83 % patient report OFNP start dental treatment . Although OFNP burden society , major cause chronic distress , disability expenditure medical resource , clinical trial assess efficacy treatment scarce . Until today , treatment OFNP extrapolate issue neuropathic pain body sit . This clinical trial first evaluate efficacy , safety , tolerance pregabalin treatment OFNP . Based result obtain neuropathic pain non trigeminal area , expect see positive result , provide evidence effective management OFNP anticonvulsant pregabalin .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Facial Pain</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Patients 18 year age old , male female history dental and/or maxillofacial treatment/surgery may cause nerve injury ( e.g . root canal treatment , implant placement , deep restoration , tooth extraction , injection anesthetic ) patient score 12 validated selfreport version Leeds Assessment Neuropathic Symptoms Signs pain scale ( SLANSS ; Bennett et al . 2005 ) extraoral site , 9 intraoral site ( score extraoral site take suggest ; intraoral site , 5point score question 2 remove score proportionally adjust , since difficult patient see color change mouth ) pain rat 4 numerical scale ( 0 pain , 10 intense pain imaginable ) , daily basis pain last 6 month absence identifiable organic lesion , inflammation infection normal serum creatinine report current previous pain medication fail provide adequate relief ( e.g. , analgesic , nonsteroidal antiinflammatories , opioids , antidepressant ) currently use medication , acceptance washout period least one week , Tylenol use rescue medication able use Palm handheld device report daily pain lactating , pregnancy ( potentially child bear patient need referral family physician state patient expect use contraception ) renal impairment renal failure ( contraindication pregabalin ) congestive heart failure liver disease currently suffer trigeminal neuralgia history mental disorder , widespread pain severe pain condition may confound pain assessment ( e.g . depression , chronic fatigue , migraine headache , fibromyalgia , severe chronic pain condition ) intolerance allergy gabapentin pregabalin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>neuropathic pain</keyword>
	<keyword>orofacial pain</keyword>
	<keyword>clinical trial</keyword>
	<keyword>pregabalin</keyword>
	<keyword>randomize control trial</keyword>
</DOC>